Protein detail

NF1

Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]

Entry name
NF1
UniProt ID
EVMP confidence score
0.50
Supporting publications (n)
2
Transmembrane count
Protein classification
Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information10
Protein Names
Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]
Protein Class (7)
Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteins
Protein Function (8)
  • Cancer-related genes:Mutational cancer driver genes
  • Predicted intracellular proteins
  • Cancer-related genes:Mutated cancer genes
  • Human disease related genes:Cancers:Cancers of endocrine organs
  • RAS pathway related proteins
  • Human disease related genes:Cancers:Cancers of haematopoietic and lymphoid tissues
  • Disease related genes
  • Human disease related genes:Congenital malformations:Other congenital malformations
Entrez Gene Symbol
Gene Description
Neurofibromin 1
Chromosome
17
Position
31094927-31382116
Supporting publications (n)
2
EVMP confidence score
0.50
Fluorescence & Localization1
NF1 fluorescence
Function & Pathway7
Protein Function (8)
  • Cancer-related genes:Mutational cancer driver genes
  • Predicted intracellular proteins
  • Cancer-related genes:Mutated cancer genes
  • Human disease related genes:Cancers:Cancers of endocrine organs
  • RAS pathway related proteins
  • Human disease related genes:Cancers:Cancers of haematopoietic and lymphoid tissues
  • Disease related genes
  • Human disease related genes:Congenital malformations:Other congenital malformations
Mediation Categories (5)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence340

Enzyme-Mediated Modification (6)

6 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
NF1PRKCAP17252S2,808phosphorylationPhosphoSite
NF1PRKCAP17252S2,829phosphorylationKEAKEA:17570479
NF1MAPK8P45983S2,515phosphorylationKEAKEA:17570479
NF1CDK1P06493S2,515phosphorylationKEAKEA:17570479
NF1CDK1P06493S864phosphorylationKEAKEA:17570479
NF1MAPK8P45983S864phosphorylationKEAKEA:17570479

Ligand-Receptor Signaling (8)

8 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularComPPINoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
intracellularintracellularUniProt_locationNoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo
transmembranetransmembraneRamilowski_locationNoNoNoNoNo
transmembranetransmembraneOmniPathNoNoNoNoNo
plasma_membraneplasma_membraneUniProt_locationNoNoNoNoNo
plasma_membraneplasma_membraneOmniPathNoNoNoNoNo

Regulatory Interaction Network (5)

5 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
NF1P21359RASHP01112YesYesYesWangSIGNORHPRDHINTIntActInnateDBSPIKE_LCSPIKEInnateDB:8628317HPRD:8628317SIGNOR:24431436HINT:8628317HINT:26635368HINT:30655611IntAct:26635368SIGNOR:19777070SPIKE_LC:19718661SPIKE:19718661
SPRE1Q7Z699NF1P21359YesYesNoHINTSIGNORHINT:26635368HINT:32697994HINT:27313208SIGNOR:32697994
NF1P21359RASKP01116YesNoYesWangHINTSIGNORSIGNOR:32697994HINT:32697994HINT:31611389
RBX2Q9UBF6NF1P21359YesNoYesSIGNORSIGNOR:23136067
KPCAP17252NF1P21359YesNoNoPhosphoSiteKEANetworKIN_KEAiPTMnetKEA:17570479PhosphoSite:26490262

Protein Complex Composition (320)

320 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
Ub:RING_E3RNF113AUBBO15541P0CG470:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF113AUBCO15541P0CG480:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF113ARPS27AO15541P629790:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF113AUBA52O15541P629870:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF151UBBP0CG47Q2KHN10:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF187UBBP0CG47Q5TA310:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF123UBBP0CG47Q5XPI40:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF19BUBBP0CG47Q6ZMZ00:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF111UBBP0CG47Q6ZNA40:0SIGNORSIGNOR:SIGNOR-C519
Ub:RING_E3RNF180UBBP0CG47Q86T960:0SIGNORSIGNOR:SIGNOR-C519
Page 4 of 32PreviousNext

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Protein Organic Solvent PrecipitationMass spectrometry132384937
Sequence, Structure & Domains14

Sequences

Length
2,839
Mass
319,372
Sequence
MAAHRPVEWVQAVVSRFDEQLPIKTGQQNTHTKVSTEHNKECLINISKYKFSLVISGLTTILKNVNNMRIFGEAAEKNLYLSQLIILDTLEKCLAGQPKDTMRLDETMLVKQLLPEICHFLHTCREGNQHAAELRNSASGVLFSLSCNNFNAVFSRISTRLQELTVCSEDNVDVHDIELLQYINVDCAKLKRLLKETAFKFKALKKVAQLAVINSLEKAFWNWVENYPDEFTKLYQIPQTDMAECAEKLFDLVDGFAESTKRKAAVWPLQIILLILCPEIIQDISKDVVDENNMNKKLFLDSLRKALAGHGGSRQLTESAAIACVKLCKASTYINWEDNSVIFLLVQSMVVDLKNLLFNPSKPFSRGSQPADVDLMIDCLVSCFRISPHNNQHFKICLAQNSPSTFHYVLVNSLHRIITNSALDWWPKIDAVYCHSVELRNMFGETLHKAVQGCGAHPAIRMAPSLTFKEKVTSLKFKEKPTDLETRSYKYLLLSMVKLIHADPKLLLCNPRKQGPETQGSTAELITGLVQLVPQSHMPEIAQEAMEALLVLHQLDSIDLWNPDAPVETFWEISSQMLFYICKKLTSHQMLSSTEILKWLREILICRNKFLLKNKQADRSSCHFLLFYGVGCDIPSSGNTSQMSMDHEELLRTPGASLRKGKGNSSMDSAAGCSGTPPICRQAQTKLEVALYMFLWNPDTEAVLVAMSCFRHLCEEADIRCGVDEVSVHNLLPNYNTFMEFASVSNMMSTGRAALQKRVMALLRRIEHPTAGNTEAWEDTHAKWEQATKLILNYPKAKMEDGQAAESLHKTIVKRRMSHVSGGGSIDLSDTDSLQEWINMTGFLCALGGVCLQQRSNSGLATYSPPMGPVSERKGSMISVMSSEGNADTPVSKFMDRLLSLMVCNHEKVGLQIRTNVKDLVGLELSPALYPMLFNKLKNTISKFFDSQGQVLLTDTNTQFVEQTIAIMKNLLDNHTEGSSEHLGQASIETMMLNLVRYVRVLGNMVHAIQIKTKLCQLVEVMMARRDDLSFCQEMKFRNKMVEYLTDWVMGTSNQAADDDVKCLTRDLDQASMEAVVSLLAGLPLQPEEGDGVELMEAKSQLFLKYFTLFMNLLNDCSEVEDESAQTGGRKRGMSRRLASLRHCTVLAMSNLLNANVDSGLMHSIGLGYHKDLQTRATFMEVLTKILQQGTEFDTLAETVLADRFERLVELVTMMGDQGELPIAMALANVVPCSQWDELARVLVTLFDSRHLLYQLLWNMFSKEVELADSMQTLFRGNSLASKIMTFCFKVYGATYLQKLLDPLLRIVITSSDWQHVSFEVDPTRLEPSESLEENQRNLLQMTEKFFHAIISSSSEFPPQLRSVCHCLYQATCHSLLNKATVKEKKENKKSVVSQRFPQNSIGAVGSAMFLRFINPAIVSPYEAGILDKKPPPRIERGLKLMSKILQSIANHVLFTKEEHMRPFNDFVKSNFDAARRFFLDIASDCPTSDAVNHSLSFISDGNVLALHRLLWNNQEKIGQYLSSNRDHKAVGRRPFDKMATLLAYLGPPEHKPVADTHWSSLNLTSSKFEEFMTRHQVHEKEEFKALKTLSIFYQAGTSKAGNPIFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPDSIPQHTKIRPKDVPGTLLNIALLNLGSSDPSLRSAAYNLLCALTCTFNLKIEGQLLETSGLCIPANNTLFIVSISKTLAANEPHLTLEFLEECISGFSKSSIELKHLCLEYMTPWLSNLVRFCKHNDDAKRQRVTAILDKLITMTINEKQMYPSIQAKIWGSLGQITDLLDVVLDSFIKTSATGGLGSIKAEVMADTAVALASGNVKLVSSKVIGRMCKIIDKTCLSPTPTLEQHLMWDDIAILARYMLMLSFNNSLDVAAHLPYLFHVVTFLVATGPLSLRASTHGLVINIIHSLCTCSQLHFSEETKQVLRLSLTEFSLPKFYLLFGISKVKSAAVIAFRSSYRDRSFSPGSYERETFALTSLETVTEALLEIMEACMRDIPTCKWLDQWTELAQRFAFQYNPSLQPRALVVFGCISKRVSHGQIKQIIRILSKALESCLKGPDTYNSQVLIEATVIALTKLQPLLNKDSPLHKALFWVAVAVLQLDEVNLYSAGTALLEQNLHTLDSLRIFNDKSPEEVFMAIRNPLEWHCKQMDHFVGLNFNSNFNFALVGHLLKGYRHPSPAIVARTVRILHTLLTLVNKHRNCDKFEVNTQSVAYLAALLTVSEEVRSRCSLKHRKSLLLTDISMENVPMDTYPIHHGDPSYRTLKETQPWSSPKGSEGYLAATYPTVGQTSPRARKSMSLDMGQPSQANTKKLLGTRKSFDHLISDTKAPKRQEMESGITTPPKMRRVAETDYEMETQRISSSQQHPHLRKVSVSESNVLLDEEVLTDPKIQALLLTVLATLVKYTTDEFDQRILYEYLAEASVVFPKVFPVVHNLLDSKINTLLSLCQDPNLLNPIHGIVQSVVYHEESPPQYQTSYLQSFGFNGLWRFAGPFSKQTQIPDYAELIVKFLDALIDTYLPGIDEETSEESLLTPTSPYPPALQSQLSITANLNLSNSMTSLATSQHSPGIDKENVELSPTTGHCNSGRTRHGSASQVQKQRSAGSFKRNSIKKIV
Alternative Products
Event=Alternative splicing; Named isoforms=6; Comment=Experimental confirmation may be lacking for some isoforms.; Name=II; IsoId=P21359-1; Sequence=Displayed; Name=I; IsoId=P21359-2; Sequence=VSP_001628; Name=3; IsoId=P21359-3; Sequence=VSP_001629, VSP_001630; Name=4; IsoId=P21359-4; Sequence=VSP_001631, VSP_001632; Name=5; IsoId=P21359-5; Sequence=VSP_043467, VSP_043468; Name=6; IsoId=P21359-6; Sequence=VSP_001628, VSP_053587
Alternative Sequence
548..551; ALLV -> VRGK (in isoform 3); 552..2839; Missing (in isoform 3); 574..593; SSQMLFYICKKLTSHQMLSS -> RYMYFYFLNSTFKFYFVFLS (in isoform 5); 594..2839; Missing (in isoform 5); 1371..1391; Missing (in isoform I and isoform 6); 1591..1598; SIFYQAGT -> TPPPEPET (in isoform 4); 1599..2839; Missing (in isoform 4); 2792; P -> PASLPCSNSAVFMQLFPHQ (in isoform 6)

3D Structural Models

Turn
31..33; 47..49; 531..534; 566..568; 693..696; 728..730; 900..903; 907..909; 947..949; 1026..1028; 1049..1052; 1201..1204; 1217..1219; 1310..1312; 1421..1425; 1582..1586; 1615..1617; 1632..1636; 1662..1664; 1698..1702; 2109..2112; 2180..2184; 2242..2244; 2285..2287; 2382..2384; 2393..2395; 2427..2429; 2443..2445; 2607..2609; 2651..2653; 2709..2715
Helix
5..18; 34..46; 51..66; 73..96; 106..111; 114..121; 130..146; 150..166; 174..181; 187..201; 206..226; 228..236; 240..256; 260..276; 278..285; 294..307; 314..331; 341..357; 373..386; 394..398; 404..419; 429..435; 436..454; 483..502; 505..508; 522..530; 539..551; 555..558; 559..561; 569..587; 593..617; 678..691; 700..708; 711..720; 724..727; 735..745; 752..762; 763..765; 771..793; 832..846; 849..851; 890..899; 910..923; 927..929; 930..942; 955..973; 979..983; 989..1000; 1006..1021; 1034..1046; 1053..1056; 1060..1063; 1064..1080; 1095..1116; 1135..1155; 1157..1160; 1162..1167; 1173..1190; 1197..1200; 1208..1216; 1220..1228; 1233..1235; 1236..1249; 1253..1267; 1271..1273; 1280..1309; 1315..1317; 1323..1325; 1332..1351; 1354..1356; 1359..1370; 1392..1394; 1398..1400; 1401..1411; 1414..1419; 1433..1451; 1459..1464; 1465..1483; 1510..1514; 1517..1520; 1531..1533; 1535..1544; 1569..1578; 1587..1590; 1610..1612; 1620..1631; 1650..1652; 1656..1661; 1668..1672; 1684..1692; 1694..1697; 1714..1717; 1721..1723; 1728..1732; 1785..1787; 1817..1833; 1847..1849; 1851..1861; 1867..1884; 1906..1918; 1920..1922; 1923..1936; 1939..1949; 1950..1952; 1957..1960; 1968..1984; 1989..2000; 2004..2006; 2007..2021; 2026..2041; 2043..2057; 2058..2060; 2061..2063; 2069..2071; 2075..2089; 2090..2092; 2096..2108; 2116..2134; 2143..2155; 2159..2165; 2173..2177; 2199..2219; 2225..2237; 2245..2250; 2252..2255; 2261..2280; 2289..2301; 2302..2304; 2311..2314; 2317..2323; 2328..2347; 2356..2363; 2365..2367; 2368..2378; 2386..2392; 2396..2399; 2403..2424; 2434..2436; 2437..2441; 2447..2452; 2613..2629; 2633..2649; 2654..2657; 2658..2671; 2675..2690; 2700..2702; 2704..2706; 2728..2742
Beta Strand
336..338; 360..362; 367..371; 387..389; 399..402; 424..426; 516..518; 1091..1093; 1277..1279; 1328..1330; 1426..1429; 1490..1492; 1592..1598; 1604..1609; 1639..1644; 1674..1681; 1706..1711; 1738..1749; 1751..1757; 1759..1767; 1770..1772; 1775..1777; 1780..1784; 1788..1795; 1798..1803; 1810..1813; 1961..1963; 1965..1967; 2137..2139; 2351..2354
3D Structure
Electron microscopy (16); X-ray crystallography (10)

Domain & Motif Annotations

Compositional Bias
2801..2827; Polar residues
Motif
2555..2571; Bipartite nuclear localization signal
Domain (CC)
Binds phospholipids via its C-terminal CRAL-TRIO domain. Binds primarily glycerophospholipids with monounsaturated C18:1 and/or C16:1 fatty acid moieties and a phosphatidylethanolamine or phosphatidylcholine headgroup. Has lesser affinity for lipids containing phosphatidylserine and phosphatidylinositol.
Domain (FT)
1251..1482; Ras-GAP; 1580..1738; CRAL-TRIO
Region
1580..1837; Lipid binding; 2787..2839; Disordered
Clinical Relevance6
Supporting Publications2
PMIDTitleAbstract
37922300Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women.No abstract available
38731868The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer.No abstract available